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ABSTRACT
In Brazil, little data is available to inform HIV prevention program-
ming for travestis and transgender (‘trans’) women, despite the
existence of a social movement that has gained strength in recent
years. We conducted formative research in Rio de Janeiro to
gather trans women’s perspectives on combination HIV preven-
tion approaches. Framing the analysis within the model of gender
affirmation, we found that several social and contextual factors
inhibited participants’ access to HIV prevention and treatment.
Experienced and anticipated gender-related discrimination and
HIV stigma were linked to the avoidance of HIV testing, health
services and HIV status disclosure. Participants recommended HIV
prevention interventions which combined socio-structural inter-
ventions, such as peer-based empowerment and social support,
with biomedical interventions such as pre-exposure prophylaxis
(PrEP). Participants expressed a preference for programmes and
interventions that emphasised a gender-affirmative approach, pro-
moted autonomy and aimed to reduce stigma and discrimination
in public health services.
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Introduction
Globally, transgender (‘trans’) women1 have 49 times higher odds of HIV infection
compared to other groups, a disparity that exists across cultures and socioeconomic
boundaries (Baral et al. 2013). Furthermore, HIV testing, engagement in care and
adherence to medication among trans women is significantly lower than other at-
risk groups (Sevelius, Carrico and Johnson 2010; Melendez and Pinto 2007). Trans
women living with HIV in the USA are estimated to have the lowest proportion of
viral suppression of any behavioural risk group (Los Angeles County Commission on
HIV 2013; Remien et al. 2015). In South America, HIV prevalence estimates among
trans women are over 30% (Dos Ramos Farias et al. 2011; Silva-Santisteban et al.
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2011), which is markedly higher than other key populations such as men who have
sex with men.
A recent study in Rio de Janeiro (Grinsztejn et al. 2017) found that 31% of trans
women recruited through respondent-driven sampling were HIV-positive and 7% of
those were new diagnoses; furthermore, almost one-third (29%) of their participants
had never been previously tested (Grinsztejn et al. 2017). Additional data corrobor-
ate that trans women are the ‘most-at-risk’ group in Brazil (De Boni, Veloso and
Grinsztejn 2014), with estimated odds of HIV infection among trans women over 55
times higher than the general Brazilian population (Costa et al. 2015), placing Brazil
among countries with the greatest HIV disparities (Baral et al. 2013). Brazilian trans
women are also disproportionately at risk for experiencing violence. The estimated
life expectancy of trans women is just 35, as opposed to 75 for cisgender (non-trans)
women; this discrepancy is largely attributable to high murder rates of trans
women in Brazil (Antunes 2010). Further, between 2008 and 2015, 802 transgender
people were murdered in Brazil, the highest reported number in the world
(Cazarre 2015).
Addressing transphobia (i.e. negative societal attitudes towards transgender
persons) as a barrier to HIV care and prevention is vital to improving health outcomes
among trans women living with or at risk of acquiring HIV in Brazil. Trans women
face a complex array of psychosocial challenges that complicate their access and
adherence to HIV care and prevention, such as limited access to and avoidance of
health care due to stigma and past negative experiences with service providers, pri-
oritisation of gender-related health care (e.g. hormone therapy and gender confirm-
ation surgery) and concerns about adverse interactions between antiretroviral
medications and hormone therapy (Sevelius et al. 2013). Social and economic margin-
alisation due to transphobia often results in poverty and unstable housing, family
alienation, limited formal education, limited social support, mental illness, trauma and
victimisation, substance abuse and introduction to sex work often at an early age
(Nuttbrock et al. 2012; Brennan et al. 2012; Bockting et al. 2013; Nemoto, B€odeker
and Iwamoto 2011; Infante, Sosa-Rubi and Cuadra 2009). These factors can result in
late or no presentation to HIV medical care and poor health outcomes (Rebchook
et al. 2017).
Increasing levels of critique have been expressed in the public health literature
of the once common practice of subsuming trans women within the behavioural risk
category of men who have sex with men (Kaplan, Sevelius and Ribeiro 2016; Minor
Peters 2016). As research illuminates the unique social contexts and needs of trans
women in the context of HIV prevention and treatment, it has become increasingly
clear that gender identity and expression are critical considerations when designing
and implementing sexual health programmes for key populations (Sevelius et al. 2016;
Poteat, German and Flynn 2016). In Brazil, researchers have documented how gender
identity intersects with access to health services, transition-related medical care and
experiences of violence and discrimination (Pinto et al. 2017; Pelucio 2009; Carrara
and Vianna 2006; Prado Cortez, Boer and Baltieri 2011). Travesti, for example, is
a complex social and cultural subjectivity in Latin America, which prior to the turn of
the twenty-first century was one of the only terms used in Brazil to indicate feminine
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gender identity among persons assigned ‘male’ at birth (Kulick 1998). Those who iden-
tify as travestis experience high levels of social vulnerability and violence (Carrara and
Vianna 2006; Prado Cortez, Boer and Baltieri 2011; Pelucio 2009) and are more likely
to inject silicone than those who identify as mulheres transexuais (transsexual women)
(Pinto et al. 2017), a term that along with mulheres trans (trans women) has become
more commonly used over the past two decades. Researchers have also emphasised
that identity categories in Brazil are fluid, the result of historical and political proc-
esses, and, as Pinto et al. (2017, 2) note, ‘do not encapsulate the subjectivities and
diversity of gender expression in this [trans] population’.2
The model of gender affirmation is a conceptual model developed in the social
and political context of the USA that examines how unmet need for gender affirm-
ation contributes to risk behaviour and diminished self-care (Sevelius 2013). Gender
affirmation here refers to an interpersonal, interactive process whereby a person
receives social recognition and support for their gender identity and expression.
Meeting trans women’s needs for gender affirmation, such as through gender-
affirming relationships and support, may decrease risk behaviour and increase self-
care (Sevelius and Johnson 2013; Colton Meier et al. 2011). Prevention programmes
targeting gay and other men who have sex with men are not typically designed to
address gender affirmation needs and transition-related health, often resulting in
low enrolment and participation by trans women. Instead, trans women often
express unique concerns about HIV prevention strategies, such as potential violence
from partners when using the HIV self-test, or concerns about potential drug–drug
interactions between pre-exposure prophylaxis (PrEP) and hormone therapy
(Lippman et al. 2015; Sevelius et al. 2016).
Guided by the model of gender affirmation, in this study we explored how
the social context of stigma and transphobia affects Brazilian trans women’s access
to health care and preferences for HIV prevention and care programming.
Acknowledging the diverse subjectivities and identity categories of trans women in
Brazil, we were particularly interested in identifying key elements to include in HIV-
related intervention programmes that seek to reach a broad range of trans women
while also addressing shared vulnerabilities, such as gender affirmation needs. We also
sought to identify additional questions for future research to fully address the diverse
and interwoven vulnerabilities that trans women face in leading safe, fulfilling and
healthy lives.
Methods
A total of 36 (of 46 invited) trans women participated in six focus groups during
the period of June–July 2015 at the Oswaldo Cruz Foundation (FIOCRUZ) in Rio de
Janeiro. The focus groups were led by health professionals with experience working
with trans communities, including a trans woman. Three focus groups were held with
21 trans women who were HIV-negative and three with 15 trans women who were
living with HIV. Our recruitment approach was multi-pronged, including in-person
recruitment at both community- and clinic-based events and telephone contacts from
lists of participants who had previously given consent to be contacted at FIOCRUZ.
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Informed consent was obtained from all individual participants included in the study.
All focus groups were conducted in Portuguese by fluent and/or native Portuguese
speakers. Incentives included lunch and travel. The focus group discussion guides were
informed by the model of gender affirmation and explored access to HIV prevention
among HIV-negative participants and HIV treatment and care among those living with
HIV. Discussion of prevention approaches included both social-behavioural (antiretroviral
medication adherence support, group- and/or individual-level risk reduction interven-
tions, increasing access to social support groups and social empowerment) and biomed-
ical strategies (PrEP, treatment as prevention [TasP], self-testing for HIV, e-health). Focus
groups were recorded with participants’ consent and transcribed with blind identifiers.
In this paper, we use pseudonyms to attribute quotes to participants.
Initial coding of the focus group transcripts was conducted using Atlas.ti software,
which permits thematic coding, annotation and visualisation of qualitative data
(Muhr 2004). Analysis involved content analysis of the transcripts, identifying sections
consistent with a priori themes based on the model of gender affirmation and the
overarching goals of the research. These included codes for social identity, codes related
to gender affirmation (e.g. access to gender affirmation, unmet need for gender
affirmation), codes relevant to experienced and anticipated stigma around both gender
identity (e.g. transphobia) and HIV (e.g. HIV-related stigma) and codes for each prevention
or care strategy. Focus group transcripts were analysed through an iterative process in
which emerging themes and new codes were included. After finalising codes, single codes
were searched and compared across the data, in addition to overlap of multiple codes
and code groups to identify patterns and associations between different analytical catego-
ries. Quotes were translated by a native English speaker fluent in Portuguese who con-
ducted the analysis, and then back-translated to Portuguese by a native Portuguese
speaker fluent in English to verify the translation. The study was approved by institutional
review boards at both the University of California, San Francisco and FIOCRUZ.
Results
Participant characteristics
Participant demographics are listed in Table 1. All reported being assigned male sex at
birth, and the majority were between the ages of 18 and 30 (42%). The majority of
participants identified as either travesti (39%) or transexual (31%). In Brazil, race and
ethnicity are commonly described in terms of categories of skin colour. In this study,
39% of participants reported being branco (white), 33% preto (Black) and 28% pardo
(brown or mixed race). In terms of HIV status, 58% reported being HIV-negative, and
42% reported being HIV-positive.
Barriers to gender affirmation: transphobia and HIV-related stigma
Microaggressions such as being called by the wrong name, or the correct name but
with disdain, were particularly common in participants’ narratives of experiences in
public health care services and were reported at all levels of service (from reception to
medically qualified providers). Institutional settings, due to reliance on rigid gender
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and sexuality categories, were ones in which HIV- and trans-related stigma and dis-
crimination were layered and intertwined. Many participants described how service
providers often associated transgender identity with HIV, and that any health prob-
lems they reported were assumed to be HIV-related.
If we arrive in a public hospital now … If I arrive with a pain here … [the response is]
to do an HIV test … Honestly, I always do the HIV test, I always have it on hand [to
show health workers]. ‘I did the test yesterday. I have pain, but I don’t have HIV’. The
prejudice is very large. (Ana, HIV-negative)
Participants’ experiences with seeking health care were described as particularly
frustrating when they were seeking care unrelated to HIV and were not offered other
types of health care without making a specific request. Participants’ fears of being
associated with HIV and the related stigma were so strong that access to care
was impeded.
I know people, friends, travestis and transexuais that have this difficulty [going to the
health clinic] … Sometimes, they are dying at home and they don’t want to go to
urgent care because [they think] ‘they are going to associate me with HIV’. (Gabriela,
HIV-positive)
Table 1. Sociodemographic characteristics (N¼ 46).
Variable N %
Age
18–30 15 42%
31–45 14 39%
46–60 7 19%
Sex at Birth
Male 36 100%
Gender Identity
Feminine 9 25%
Woman 2 6%
Transexual 11 31%
Travesti 14 39%
Sexual Orientation
Bisexual 1 3%
Heterosexual 12 33%
Homosexual 18 50%
Other 5 14%
Skin Colour (cultural classification used in Brazil)
White 14 39%
Black 12 33%
Brown 10 28%
Education
Primary School (Complete) 14 39%
Primary School (Incomplete) 9 25%
High School 11 31%
College 2 6%
Income
R$0 10 28%
R$300–R$900 11 31%
R$901–R$1500 13 36%
>R$1500 2 6%
HIV Status
Positive 15 42%
Negative 21 58%
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An additional barrier to seeking care was not having one’s social name respected,
despite the fact that federal laws and decrees in Brazil mandate the use of social
names in public health clinics and schools. For many, the idea of being called by their
male birth name in public was enough to avoid going to the clinic.
The first barrier that exists among us travestis and transexuais is the social name … You
arrive sick at a hospital to do a CD4 [count] … and the nurse calls you by the name
‘Jo~ao’ … So you don’t go back for the next appointment. Instead you say, ‘Shoot, I’m
going to be called Jo~ao again … I am very weak, I’m just going to stay here’. And you
stay at home. A friend of mine died at home because of this. (Mariana, HIV-negative)
This disconnect between policy and practice in terms of the civil rights of trans
people in Brazil was observed in all of the focus groups. There was a sense among
participants that negative experiences such as these are inevitable, despite the fact
that the civil and social rights of trans communities are recognised by the State. The
following participant emphasises how civil and social rights are no guarantee against
stigma and discrimination:
Travestis and transexuais have civil and social rights, people say that they have these
rights, but you see people don’t respect travestis and transexuais. They are always going
to discriminate. (Camila, HIV-positive)
Even when identity terms were respected, participants felt that it was not always in
the spirit of support and sincerity: ‘My issue is respect, understand? … It doesn’t mat-
ter if you call me by a woman’s name if it’s going to be with a tone of debauchery,
understand?’ (Leticia, HIV-negative).
Violence limits prevention empowerment and HIV status disclosure
Even though the focus group discussion guide did not ask specifically about it, vio-
lence was recurrent in the narratives of trans women’s private lives, especially in
regard to partner reactions to discussion related to HIV. Participants described violent
reactions to suggestions of HIV prevention methods, such as condoms, which often
led to avoidance of sex and fearing intimate relationships in general:
One time I went to have sex with a person and when I said that I would only have sex
with condoms, he had an extremely aggressive attitude … he tried to physically hurt me
… It was, like this, he kept me here and said, ‘what are you thinking, viado [fag], that I
am sick? It is you all who pass on diseases to others, not me, not me. I am married, I
have my wife, I have my children’. This traumatised me so much that I spent three
months without having sex with anyone, out of fear. (Juliana, HIV-negative)
In addition to violence, the quote highlights something of the stigma associated
with trans identity and HIV, whereby married men with wives and children are seen as
‘clean’ and trans women are associated with ‘disease’. Experiences such as these had
strong repercussions for some participants in terms of avoiding sex and fearing violent
reactions to suggesting HIV prevention methods and discussing HIV status
with partners.
Fear of violence influenced decisions not to disclose HIV status to partners: ‘I am
not going to come up to someone, a friend who I don’t know, who is outside my day-
to-day and say, “Ah, I have HIV” … He is going to beat me’ (Luiza, HIV-positive).
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Perceptions of PrEP and the HIV self-test
Participants expressed the desire to avoid medical settings as much as possible due to
enacted and anticipated stigma, and concerns about confidentiality. Biomedical pre-
vention technologies such as PrEP, HIV self-testing (available in Brazil since 2015) and
TasP were considered attractive options for protection beyond condom use and for
increasing one’s autonomy from medical settings.
Some participants were concerned that PrEP could make people feel invulnerable
to HIV, like ‘Popeye’s Spinach’ as one participant described it, potentially leading to an
increase in unprotected sex and the onward transmission of HIV.
Just like they don’t know about the test, about prevention, they are not going to have a
clue that, ‘oh, if I take one I don’t need the other’ … They have to keep having the same
information, because if they don’t, they are going to think that PrEP is going to turn
them into a steel plate of immunity … ‘I can’t get it, it doesn’t matter, I am taking PrEP
and that’s it …’ (Vitoria, HIV-negative)
Furthermore, some participants expressed distrust regarding PrEP’s efficacy:
My partner and I are part of the PrEP project, but even so, I don’t trust it. I don’t think
that a pill is going to totally prevent [HIV]. I have other partners in my life. And him, I
don’t know. We don’t have the virus, but … I don’t know what he does in the street.
Sometimes I have sex with someone who says they don’t have it … But I always take it
[PrEP] and also use condoms because I don’t trust it [PrEP]. (Clara, HIV-negative)
Participants emphasised that while it was a priority to make PrEP widely available,
it was equally important to ensure that it is distributed with accurate information:
The question for me is not about where. For me, it [PrEP] could be distributed at the
bakery, it is just that the problem is not distribution, the problem is the lack of
information. (Juliana, HIV negative)
Lack of information about PrEP was seen as contributing to HIV-related stigma
towards those who use it. One participant described how when others found out that
she was taking it, they assumed that she was HIV-positive.
Let’s talk about PrEP … for as much as I had said that it was a treatment for pre-
exposure, people called me, sent me Facebook messages, others more openly asked if I
was sick. (Juliana, HIV-negative)
HIV-related stigma also influenced how participants perceived HIV self-testing. Few
had heard of it, and while many thought it was interesting in terms of offering ease,
privacy and autonomy especially in terms of being able to avoid the health clinic, they
were concerned about people not being psychologically prepared for the results.
Not everyone has a psychologist, not everyone has support … I am going to be sincere
with you, I don’t have the support to know if I have HIV or not, doctor. (Aline,
HIV-negative)
No one is emotionally prepared to do one of these HIV tests at home. I think that they
should at least have … they should be sold like black-labelled medicine is sold, with a
medical prescription. Because it is a very serious thing for you to go to the pharmacy like
someone who is going to buy medicine for a headache medicine and include in your
basket a self-test to know if I have HIV. (Leticia, HIV-negative)
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Concerns were also expressed that the HIV self-test could be imposed on them by
clients or partners and provoke a violent reaction should they test positive. The follow-
ing participant saw risks from both her clients as a sex worker and her steady partner.
I’m a sex worker and we’re subject to a lot of risks, right? What if I get one of those types
of guys, like has happened before, that puts a gun to my head and says, ‘do the test
now. If in 20minutes it’s positive, I’ll kill you’. And now what do I do!? Then I am a
seropositive trans and I didn’t want to do the test, but I had to because there was a gun
to my head and they found out that I am [HIV positive], they kill me, and it’s over … I
wouldn’t do it alone, and I would only do it in front of him [boyfriend] if he made me.
Because if it is positive, he is going to want to kill me! (Clara, HIV-negative)
These concerns were primarily related to the test being used in a situation that
could potentially lead a person to feeling depressed or experiencing violence. A key
theme was that the decision to use the HIV self-test should be the person’s own and
should be conducted in a supportive situation where they would be prepared for the
result. A few participants felt that it was important to respect a person’s privacy and
to regard one’s decision to request the test as a sign that the person is ready to
take it.
You have to think that if the person is going to go to a pharmacy and buy a test to do at
home it is because she wants to know and doesn’t want to seek out a professional; she
wants to keep it to herself. (Leticia, HIV-negative)
In a similar vein, another participant commented that being able to avoid therapists
and the fear that they often provoke in people regarding HIV could be liberating:
I am in favour of having the test in any pharmacy, I am 100% in favour of it. Why?
Because sometimes there really is a psychological terror that comes from psychologists
and psychiatrists … Because he is trying to show us the risk that we are running, and for
us to avoid it … It’s a drag. The first time that I did an HIV test in my life I almost peed
my pants. Perhaps just going to the pharmacy would liberate one from the psychological
terror that they feel. Of course, if you want to kill yourself, if you discover it at the
medical clinic or in the pharmacy, you are going to kill yourself either way. (Ana,
HIV-negative)
Access to gender affirmation: social and behavioural intervention programming
The perceived positive aspects of biomedical technologies such as increasing auton-
omy from public health services and providing additional protection were also
reflected in participants’ interest in social interventions that would build peer support
and solidarity networks. Participants suggested that programming should have both
trans-specific and more general activities, including covering topics beyond HIV.
It [group level interventions] would work if it had a little something more …We travestis
and transexuais need more … because I don’t make a living just by going to meetings,
just snacks and Coca-Cola. Outside of here I am the one who knows about my life. I have
to do things myself. So, I don’t present myself as a victim, I am not a victim at all! But I
think the way you [facilitator] talk about the activities is perfect, it is just that it has to
have a little more. And then when this activity is over, when this meeting is over, we go
back to the street? (Mariana, HIV-negative)
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Increasing autonomy included the desire for groups to go beyond being safe
spaces for discussion to offering concrete skills. As the above participant mentions,
the meetings are not perceived as being enough to change their circumstances out-
side of the group space. It was important to many that group spaces recognise the
structural barriers that were described as more central to trans women’s well-being
than HIV.
To respond to your question, the travestis and transexuais there where I live don’t like to
talk about HIV, they don’t like to talk about the HIV test, they don’t like to talk about any
of that. They barely talk about condoms … generally [we talk about] topics of militancy,
professional disillusion, etc. … these types of things … But to talk about STDs in
general, the girls, many of the girls that I know don’t talk about it, they don’t like it …
They don’t like to participate in conversations and they don’t let you insist. (Juliana,
HIV-negative)
The majority of participants emphasised that support groups and empowerment-
based group interventions should be open both in terms of serostatus and gender
identity. Some participants felt that separating groups by serostatus would reduce HIV
stigma, whereas others felt it was important to have mixed groups to avoid highlight-
ing differences and identifying who was positive and who was not. As Gabriela stated,
‘if you separated meetings for HIV-positive and HIV-negative, [people will say], “look,
the positives are leaving the room”, I don’t think that’s cool’ (Gabriela, HIV-positive).
Overall, the sense was that serostatus-inclusive groups were preferred. As one partici-
pant shared, ‘Having something mixed would be good to open up people’s minds’
(Cristina, HIV-positive).
In terms of gender identity, the discussions revealed that many participants thought
of themselves and their own identities as fluid, largely depending on the context and
who was defining the categories. For some, the term travesti held negative connota-
tions and associations, and they preferred the words trans or transexual which were
associated with desire for a more ‘respectable’ identity term and subjectivity. For
others, using the term travesti was source of pride and a political decision to fight the
stigma associated with the term. Perceived connections between identity and sexual
risk behaviour, such as assumptions about travesti identity and engagement in sex
work, were recurrent themes throughout the focus groups. These perceived connec-
tions are critical to consider in terms of trans-specific information networks and HIV
programming and intervention planning.
Importance of trans-specific information networks
Participants trusted information more when it came from other trans women than
from health care providers, and for this reason they valued peer educators and saw
having peers in the family clinics near their homes as crucial to successful prevention
and treatment. Services that employed trans women were seen as more desirable
because, as one participant stated, ‘I feel more at home’ Juliana, HIV-negative. Even if
other non-trans staff members were welcoming and supportive, this was not perceived
as equal to having a peer:
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I came here to FIOCRUZ because there is a trans person [uma pessoa trans] who knows
how to talk like me, like all of us, she speaks the same language and makes us feel
considered, we feel welcome thanks to her. The other boys here are cool, but they aren’t
the same as us. (Ana, HIV negative)
Participants living with HIV in particular emphasised the importance of having a
trans staff person in the family clinic close to their homes.
It’d be a dream, imagine? Let’s say that a travesti lives in Penha and tomorrow, for
whatever motive gets infected … Then she goes to the nearest health post, and there is
someone there, a well-trained travesti that was trained for this [purpose] and will
understand me. (Camila, HIV-positive)
Some of the participants worked as peer educators and shared their experiences
from doing outreach work.
Last week I went to hand out condoms at [place] and a bicha [slang for gay men and
trans women] said, ‘Oh, I want so much to do it [get tested for HIV], but I am so afraid’
and then another one got into our conversation and started to say that she had HIV. ‘I
have it and I need to take care of myself’, then I said, ‘shoot, I’ve had HIV since I was 18,
I’ve had the virus for 42 years’. She said, ‘you’re lying! Really?’ and I said, ‘Yes’. She said,
‘What do I need to do to be tested?’ and then I invited her. (Lorena, HIV-positive)
At the same time, the strength of community ties and sharing of experiences across
networks can result in one negative experience affecting many people. In the follow-
ing quote, a participant mentioned how she decided not to identify openly as a trans
woman at a hepatitis C and HIV testing campaign after perceiving that a campaign
volunteer had laughed and poked fun at another travesti ahead of her.
I saw someone who looked like a travesti. I kept observing her, and when it was time for
her to be tested, the volunteer poked someone else and laughed. I observed from far
away and was like, ‘Ah, I am going to be tested, should I say that I am a trans woman
[uma mulher trans] or should I stay quiet and be tested?’ I arrived [at the reception desk]
… feminine sex. The girl didn’t question anything … I could have said, ‘I am a trans
woman [uma mulher trans]’, but since she had joked before, with the other girl, that
didn’t make me feel comfortable. (Paola, HIV-negative)
These interactions, and the subsequent sharing of personal stories, may hold more
weight than any campaign or training provided by health clinics, as it is primarily from
personal experiences and the stories of others that participants’ perceptions of health
services and HIV were formed. Social networks and the support of peers are highly val-
ued in HIV programming, and health professionals should be cognisant of the far-
reaching effects of stigmatising and discriminatory treatment they may enact towards
trans women.
Discussion
This study sought to identify optimal elements of HIV programming for trans women
in Brazil from the perspective of lived experiences of trans women, those living with
HIV and those who are not, through the lens of the model of gender affirmation. Our
findings include important insights from trans women’s experiences in the public
health system that may be leveraged to expand access to and improve the quality of
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health care for trans women in Brazil. Participants provided input on both biological
and behavioural prevention strategies as well as a variety of programmatic and con-
ceptual frameworks for intervention design. Participants emphasised the importance
of a gender-affirming, combination prevention approach that promotes a balance of
autonomy, reaffirms the importance of peer support and solidarity, moves beyond an
HIV-only vision of health and addresses systemic stigma, discrimination and violence
in public health services and their home communities.
In describing ideal intervention designs, trans women described two interrelated
considerations: the need to avoid stigma, violence and discrimination, and the desire
for gender-affirming and empowering services, preferably delivered by peers.
Addressing unmet need for gender affirmation among trans women in the context of
HIV prevention can help to address the medical mistrust that stems from previous
experiences of microaggression and transphobia when seeking medical care.
Furthermore, increasing trust by using peer staff in the delivery of such interventions
is also likely to increase participation, the motivation for self-care and empowerment
through modelling employment options for trans women.
Biomedical technologies such as PrEP and HIV self-testing, while viewed with scepti-
cism by some, were generally regarded as important developments in increasing the
autonomy of trans women in having control over their own HIV prevention strategies and
knowledge of their own status. The avoidance of public health systems is a strategy
widely used by trans women to protect themselves in the immediate sense. However,
public health care systems must be held accountable to their mandate to improve their
ability to serve trans women in an affirming and respectful manner. Furthermore, in
designing future combination prevention approaches for trans women in Brazil, it is
important to attend to differences and affirm participants’ identities by using terminolo-
gies that they are comfortable with. While participants did not necessarily always agree
on what could be assumed about a person based on their identity as a travesti, trans or
transexual woman, it was clear that these terms were very important in both a personal
sense and in community interactions. The nuances and weight of these identities must be
attended to when designing HIV programming for trans women in Brazil.
In Brazil, and in similar settings where universal health care is available at no
charge, researchers have called attention to the importance of addressing stigma and
discrimination within a vulnerability and human rights framework in order to reduce
the most severe health disparities experienced by the most vulnerable populations
(Paiva, Ayres and Buchalla 2012). Our findings revealed that while Brazil has progres-
sive public policies to protect trans civil rights, participants experienced pervasive
stigma and discrimination, indicating that their lived experiences do not reflect these
protections. Even the most basic principles of Brazil’s universal health care system,
such as equity and access, have been difficult to guarantee on a broad scale. The
nationwide evaluation of the country’s Centros de Testagem e Aconselhamento (TAS)
(counselling and testing services) conducted by the Ministry of Health found that
access to services was especially low among the most vulnerable groups and that the
TAS did not prioritise reaching these groups (Grangeiro and Ferraz 2008). Thus, trans
people and other vulnerable groups have demonstrated particular difficulty accessing
HIV counselling and testing.
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Of particular concern is the current political and economic crisis in Brazil whereby
the public health system is under threat. A Constitutional Amendment was passed in
2016 that froze the already underfunded health and education budgets for 20 years.
Issues such as shortage of personnel, lack of adequate training and stockouts of drugs
and supplies have made Brazilian AIDS policies particularly difficult to implement with
vulnerable groups (da Fonseca and Bastos 2017). Additionally, there has been an
increase in conservatism in Brazil that has been associated with the censorship of HIV
prevention campaigns and sexual education materials (Malta and Beyrer 2013; Paiva
and Silva 2015). This situation has led some researchers and activist groups to publicly
denounce what they see as a shift away from human rights approaches that historic-
ally informed the Brazilian HIV response (Malta and Beyrer 2013; Seffner and Parker
2016; Paiva and Silva 2015; Scheffer and Rosenthan 2014). We hypothesise that if
access to the Sistema Unico de Saude (SUS; or single health system, Brazil’s public
health care system) is hampered by ongoing discrimination in the context of shrinking
resources and moral conservatism, the barriers to health care currently experienced by
trans women in Brazil will increase.
Limitations
While our study sample was diverse in terms of age, gender identity, sexual orien-
tation, skin colour, education and income, the following limitations should be con-
sidered when interpreting our findings. The sample size was too small to permit
meaningful comparisons or stratification along demographic dimensions; however,
the diversity of participants helped to ensure a rich dialogue that included a var-
iety of perspectives. Length of time since transition was not measured, as this con-
struct can be difficult to operationalise; thus, it is possible that trans women may
have different experiences with health care based on transition status. Our sample
was drawn from a primarily urban population in Rio do Janeiro and may not gener-
alise to less urban areas of Brazil. While focus group facilitators were health profes-
sionals (including a trans woman) with extensive experience conducting qualitative
research and working with trans women, it is possible that their professional status
may have influenced the willingness of the participants to discuss certain barriers
to health care.
Conclusion
To ensure universal and safe access to care for trans people, future programmes
and interventions must address structural issues (e.g. stigma, gender affirmation,
employment, violence) not as complementary to other components, but as central
to trans women’s ability to survive. Our data strongly support a gender-affirming
approach to trans health, in which HIV programming for trans women is not lim-
ited to individual and biomedical strategies such as greater PrEP uptake or higher
HIV testing rates but affirms the diverse subjectivities of trans women and supports
their autonomy as they cultivate health and empowerment both for themselves
and their communities.
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Notes
1. To respect the diversity of terms in Brazil and the discussions within the international
literature (Dourado et al. 2016), in this paper we use the umbrella term ‘trans women’ in
English to refer to people assigned ‘male’ at birth who identify as female, transgender or
transsexual. Throughout the paper we retain the original terms in Portuguese used by
participants to describe their gender identities (in italics).
2. An in-depth discussion of US trans identities in Brazil is beyond the scope of this article;
we direct the reader to Kulick (1998) and Garcia (2009).
Acknowledgements
This research was supported by a grant from the US National Institutes of Health, University of
California, San Francisco, Center for AIDS Prevention Studies, #P30MH062246. Much appreciation
to Lissa Moran for the coordination of this project and to the following individuals who pro-
vided critical input: Cristiane Regina Vinissius de Castro, Laylla Monteiro, Kakau Ferreira, Biancka
Fernandes and our study participants.
Disclosure statement
No potential conflict of interest was reported by the authors.
Funding
US National Institute of Mental Health.
ORCID
Laura Rebecca Murray http://orcid.org/0000-0002-6245-2227
References
Antunes, P. P. S.. 2010. Travestis Envelecem? Annablume: Pontifıcia Universidade Catolica de S~ao
Paulo.
Baral, S. D., T. Poteat, S. Stromdahl, A. L. Wirtz, T. E. Guadamuz, and C. Beyrer. 2013. "Worldwide
Burden of HIV in Transgender Women: A Systematic Review and Meta-Analysis." The Lancet
Infectious Diseases 13 (3): 214–22.
Bockting, W. O., M. H. Miner, R. E. Swinburne Romine, A. Hamilton, and E. Coleman. 2013.
"Stigma, Mental Health, and Resilience in an Online Sample of the US Transgender
Population." American Journal of Public Health 103 (5): 943–951.
Brennan, J., L. M. Kuhns, A. K. Johnson, M. Belzer, E. C. Wilson, and R. Garofalo. 2012. "Syndemic
Theory and HIV-Related Risk among Young Transgender Women: The Role of Multiple, Co-
Occurring Health Problems and Social Marginalization." American Journal of Public Health 102
(9): 1751–1757.
Carrara, S., and A. Vianna. 2006. "“Ta La O Corpo Estendido No Ch~ao…”: A Violencia Letal Contra
Travestis No Municipio Do Rio De Janeiro." Physis: Revista de Saude Coletiva 16 (2): 233–249.
Cazarre, M. 2015. Com 600 Mortes Em Seis Anos, Brasil E O Que Mais Mata Travestis E
Transexuais. Direitos Humanos. Accessed 30 Oct 2017. http://agenciabrasil.ebc.com.br/direitos-
humanos/noticia/2015-11/com-600-mortes-em-seis-anos-brasil-e-o-que-mais-mata-travestis-e
Colton Meier, S. L., K. M. Fitzgerald, S. T. Pardo, and J. Babcock. 2011. "The Effects of Hormonal
Gender Affirmation Treatment on Mental Health in Female-to-Male Transsexuals." Journal of
Gay & Lesbian Mental Health 15 (3): 281–299.
CULTURE, HEALTH & SEXUALITY 13
Costa, A. B., A. M. Fontanari, M. M. Jacinto, D. C. da Silva, E. K. Lorencetti, H. T. da Rosa Filho, A.
Mueller, C. G. de Garcia, H. C. Nardi, S. H. Koller, and M. I. Lobato. 2015. "Population-Based
HIV Prevalence and Associated Factors in Male-to-Female Transsexuals from Southern Brazil."
Archives of Sexual Behavior 44 (2): 521–524.
da Fonseca, E. M., and F. I. Bastos. 2017. "Evolution of HIV/AIDS Response in Brazil: Policy
Innovations and Challenges in the Fourth Decade of the Epidemic." The International Journal
of Health Planning and Management 33 (1): e238–e250. doi:10.1002/hpm.2452
De Boni, R., V. G. Veloso, and B. Grinsztejn. 2014. "Epidemiology of HIV in Latin America and the
Caribbean." Current Opinion on HIV & AIDS 9 (2): 192–198.
Dos Ramos Farias, M. S., M. N. Garcia, E. Reynaga, M. Romero, M. L. Vaulet, M. R. Fermepin, M. F.
Toscano, J. Rey, R. Marone, L. Squiquera, et al. 2011. "First Report on Sexually Transmitted
Infections among Trans (Male to Female Transvestites, Transsexuals, or Transgender) and Male
Sex Workers in Argentina: High HIV, HPV, HBV, and Syphilis Prevalence." International Journal
of Infectious Diseases 15 (9): e635–e640.
Dourado, I., L. A. Silva, L. Magno, M. Lopes, C. Cerqueira, A. Prates, S. Brignol, and S. MacCarthy.
2016. "[Building Bridges: Interdisciplinarity in Practice. Poptrans Study: A Study with
Transvestites and Transsexual Women in Salvador, Bahia State, Brazil]." Cadernos de Saude
Publica 32 (9): e00180415.
Garcia, M. R. V. 2009. "Identity as a ‘Patchwork’: Aspects of Identity among Low-Income Brazilian
Travestis." Culture, Health & Sexuality 11 (6): 611–623.
Grangeiro, A., and D. Ferraz. 2008. Centros De Testagem E Aconselhamento Do Brasil: Desafios
Para a Equ€Idade E O Acesso. Brasilia: Ministerio da Saude.
Grinsztejn, B., E. M. Jalil, L. Monteiro, L. Velasque, R. I. Moreira, A. C. F. Garcia, C. V. Castro, A.
Kr€uger, P. M. Luz, A. Y. Liu, et al. 2017. "Unveiling of HIV Dynamics among Transgender
Women: A Respondent-Driven Sampling Study in Rio De Janeiro, Brazil." The Lancet HIV 4 (4):
e169–e176.
Infante, C., S. G. Sosa-Rubi, and S. M. Cuadra. 2009. "Sex Work in Mexico: Vulnerability of Male,
Travesti, Transgender and Transsexual Sex Workers." Culture, Health & Sexuality 11 (2):
125–137.
Kaplan, R. L., J. Sevelius, and K. Ribeiro. 2016. "In the Name of Brevity: The Problem with Binary
Hiv Risk Categories." Global Public Health 11 (7-8): 824–834.
Kulick, D.. 1998. Travesti: Sex, Gender, and Culture among Brazilian Transgendered Prostitutes.
Chicago, IL: University of Chicago Press.
Lippman, S. A., L. Moran, J. Sevelius, L. S. Castillo, A. Ventura, S. Treves-Kagan, and S.
Buchbinder. 2015. "Acceptability and Feasibility of HIV Self-Testing among Transgender
Women in San Francisco: A Mixed Methods Pilot Study." AIDS & Behavior 20 (4): 928–938.
Los Angeles County Commission on HIV. 2013. Los Angeles County Five-Year Comprehensive
HIV Plan (2013–2017). Edited by Division of HIV and STD Programs. Los Angeles County HIV
Prevention Planning Committee, Los Angeles County Department of Public Health.
Malta, M., and C. Beyrer. 2013. "The HIV Epidemic and Human Rights Violations in Brazil." Journal
of the International AIDS Society 16: 18817.
Melendez, R. M., and R. Pinto. 2007. "’It’s Really a Hard Life’: Love, Gender and HIV Risk among
Male-to-Female Transgender Persons." Culture, Health and Sexuality 9 (3): 233–245.
Minor Peters, M.. 2016. "‘They Wrote “Gay” on Her File’: Transgender Ugandans in HIV
Prevention and Treatment." Culture, Health & Sexuality 18 (1): 84–98.
Muhr, T. 2004. User’s Manual for Atlas.Ti 5.0. GmbH, Berlin: ATLAS.ti Scientific Software
Development.
Nemoto, T. N., B. B€odeker, and M. Iwamoto. 2011. "Social Support, Exposure to Violence and
Transphobia, and Correlates of Depression among Male-to-Female Transgender Women with
a History of Sex Work." American Journal of Public Health 101 (10): 1980–1988.
Nuttbrock, L. A., W. Bockting, A. Rosenblum, S. Hwahng, M. Mason, M. Macri, and J. Becker.
2012. "Gender Abuse, Depressive Symptoms, and HIV and Other Sexually Transmitted
Infections among Male-to-Female Transgender Persons: A Three-Year Prospective Study."
American Journal of Public Health 105 (2): 300–307.
14 J. SEVELIUS ET AL.
Paiva, V., J. R. Ayres, and C. Buchalla. 2012. Vulnerbilidade E Direitos Humanos, Prevenc¸~ao E
Promoc¸~ao Da Saude. Livro I: Da Doenc¸a A Cidadania [Vulnerability and Human Rights,
Prevention and Health Promotion. Book 1: From Sickness to Citizenship] Curitiba: Jurua
Editora.
Paiva, V., and V. N. Silva. 2015. "Facing Negative Reactions to Sexuality Education through a
Multicultural Human Rights Framework." Reproductive Health Matters 23: 96–106.
Pelucio, L.. 2009. Abjec¸~ao E Desejo - Uma Etnografia Travesti Sobre O Modelo Preventivo De Aids.
S~ao Paulo: Editora Annablume.
Pinto, T. P., F. D. B. Teixeira, Crds Barros, R. B. Martins, G. S. R. Saggese, D. D. Barros, and
M. A. S. M. Veras. 2017. "[Use of Industrial Liquid Silicone to Transform the Body: Prevalence
and Factors Associated with Its Use among Transvestites and Transsexual Women in S~ao
Paulo, Brazil]." Cadernos de Saude Publica 33 (7).
Poteat, T., D. German, and C. Flynn. 2016. "The Conflation of Gender and Sex: Gaps and
Opportunities in HIV Data among Transgender Women and MSM." Global Public Health 11 (7-
8): 835–848.
Prado Cortez, F. C., D. P. Boer, and D. A. Baltieri. 2011. "A Psychosocial Study of Male-to-Female
Transgendered and Male Hustler Sex Workers in S~ao Paulo, Brazil." Archives of Sexual Behavior
40 (6): 1223–1231.
Rebchook, G., J. Keatley, R. Contreras, J. Perloff, L. F. Molano, C. J. Reback, K. Ducheny, T.
Nemoto, R. Lin, J. Birnbaum, T. Woods, J. Xavier, and Spns Transgender Women of Color
Study Group. 2017. "The Transgender Women of Color Initiative: Implementing and
Evaluating Innovative Interventions to Enhance Engagement and Retention in HIV Care."
American Journal of Public Health 107 (2): 224–229.
Remien, R. H., L. J. Bauman, J. E. Mantell, B. Tsoi, J. Lopez-Rios, R. Chhabra, A. DiCarlo, D.
Watnick, A. Rivera, N. Teitelman, B. Cutler, and P. Warne. 2015. "Barriers and Facilitators to
Engagement of Vulnerable Populations in HIV Primary Care in New York City." Journal of
Acquired Immune Deficiency Syndromes 69: S16–S24.
Scheffer, M., and C. Rosenthan. 2014. "Para Acabar Com Aids No Brasil." Folha de S~ao Paulo,
January 12, 2014.
Seffner, F., and R. Parker. 2016. "The Neoliberalization of HIV Prevention in Brazil " In Myth Vs.
Reality: Evaluating the Brazilian Response to HIV in 2016, edited by Angelica B., Richard P. and
V. T. Junior, 22–30. Rio de Janeiro: Brazilian Interdisciplinary AIDS Association (ABIA) - Global
AIDS Policy Watch.
Sevelius, J. M. 2013. "Gender Affirmation: A Framework for Conceptualizing Risk Behavior among
Transgender Women of Color." Sex Roles 68 (11-12): 675–689.
Sevelius, J. M., A. Carrico, and M. O. Johnson. 2010. "Antiretroviral Therapy Adherence among
Transgender Women Living with HIV." Journal of the Association of Nurses in AIDS Care 21 (3):
256–64.
Sevelius, J. M., and M. O. Johnson. 2013. "Preliminary Support for Transgender-Specific
Predictors of Uptake and Adherence to ART and Viral Load among HIVþ Transgender
Women." 8th International Conference on HIV Treatment and Prevention Adherence, June.
Sevelius, .J. M., J. Keatley, N. Calma, and E. Arnold. 2016. "“I Am Not a Man”: Trans-Specific
Barriers and Facilitators to Prep Acceptability among Transgender Women." Global Public
Health 11 (7–8): 1060–1075.
Sevelius, J. M., E. Patouhas, J. G. Keatley, and M. O. Johnson. 2013. "Barriers and Facilitators to
Engagement and Retention in Care among Transgender Women Living with Human
Immunodeficiency Virus." Annals of Behavioral Medicine 47 (1): 5–16.
Silva-Santisteban, A., H. F. Raymond, X. Salazar, J. Villayzan, S. Leon, W. McFarland, and C. F.
Caceres. 2011. "Understanding the HIV/AIDS Epidemic in Transgender Women of Lima, Peru:
Results from a Sero-Epidemiologic Study Using Respondent Driven Sampling." AIDS &
Behavior 16 (4): 872–881.
CULTURE, HEALTH & SEXUALITY 15
